{"version":"1.0","provider_name":"FIFARMA","provider_url":"https:\/\/fifarma.org\/en","title":"Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP)","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"7U2b8s5WOG\"><a href=\"https:\/\/fifarma.org\/en\/publicaciones\/observatorio-de-buenas-practicas-regulatorias\/\">Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP)<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/fifarma.org\/en\/publicaciones\/observatorio-de-buenas-practicas-regulatorias\/embed\/#?secret=7U2b8s5WOG\" width=\"600\" height=\"338\" title=\"&#8220;Observatorio de Buenas Pr\u00e1cticas Regulatorias (ESP)&#8221; &#8212; FIFARMA\" data-secret=\"7U2b8s5WOG\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/fifarma.org\/wp-includes\/js\/wp-embed.min.js\n<\/script>","description":"Este informe es un an\u00e1lisis independiente sobre la adopci\u00f3n de las Buenas Pr\u00e1cticas Regulatorias (BPR) en la regulaci\u00f3n de productos farmac\u00e9uticos en ocho (8) pa\u00edses de Am\u00e9rica Latina.La informaci\u00f3n proviene de fuentes confiables, sin embargo, los datos e informaci\u00f3n aqu\u00ed descrita estar\u00e1n sujetos a ser actualizados y validados. Este estudio no es una evaluaci\u00f3n del [&hellip;]"}